Good point Ahjay. If Lag3 is the door to a major advance in the immune treatment landscape( appears likely), then Immutep is the master key.
Which means, we are going to be valuable!
- Forums
- ASX - By Stock
- IMM
- Lag-3 Research Operative
Lag-3 Research Operative, page-7
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $450.9M |
Open | High | Low | Value | Volume |
31.5¢ | 31.8¢ | 30.5¢ | $641.8K | 2.070M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 57037 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 86970 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
45 | 298439 | 0.305 |
30 | 508889 | 0.300 |
13 | 161139 | 0.295 |
15 | 344235 | 0.290 |
13 | 1252600 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 92970 | 11 |
0.315 | 181827 | 12 |
0.320 | 118000 | 10 |
0.325 | 257229 | 9 |
0.330 | 75645 | 9 |
Last trade - 14.22pm 17/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online